Literature DB >> 25789224

Vasorelaxant effect of 17α-ethynylestradiol on human saphenous vein.

Ahmad Reza Jodati1, Hossein Babaei2, Yadollah Azarmi3, Sahar Fallah3, Afsaneh Gharebageri4, Danial Fadaei Fouladi4, Naser Safaei1.   

Abstract

PURPOSE: A protective effect for estrogens against cardiovascular problems has long been known. The aim of this study was to investigate the vasorelaxant effect of 17α-Ethynylestradiol (17α-EE) on human saphenous vein.
METHODS: The veins were suspended horizontally between two triangular stainless steel hooks for the measurement of isometric tension in individual organ baths containing 10ml Krebs solution, at 37°C and gassed with carbogen under 3gr optimum tension. The effect of different concentrations of 17α-EE (2-40 μM) on vascular tone was investigated in veins precontracted with PGF2α. Relaxation was measured after 40min and expressed as the percent decrease of initial contraction. To determine the involvement of potassium channels, endothelium, nitric oxide synthase, guanylylcyclase and prostaglandins in the vasorelaxant effect of estrogen, the veins were incubated with tetraethyl ammonium, N-nitro-L-arginine methyl ester, methylene blue or indomethacin, respectively for 20min prior to experimentation. Responses to 17α-EE were directly compared to those obtained in the same tissues in the absence of the inhibitors.
RESULTS: The mean relaxations induced by 17α-EE with concentrations of 2, 5, 10, 20 and 40μM in tissues precontracted with PGF2α were 19.8 ±5.5%, 26.1±10.8%, 32.2±7.4%, 48.6±10.8%and56±7.6%, respectively. The results of the inhibition of potassium channels, nitric oxide synthase, guanylylcyclase, cyclooxygenase and removing endothelium in relaxation induced by 17α-EE on precontracted veins with PGF2α proved no significant differences.
CONCLUSION: This study showed that 17α-EE has significant vasorelaxant effect on human saphenous vein in a concentration-dependent manner. This effect is probably independent of potassium channels, nitric oxide synthase, guanylylcyclase, prostaglandin synthesis and endothelium functions.

Entities:  

Keywords:  17α- Ethynylestradiol; Estrogen; Saphenous Vein; Vasorelaxation

Year:  2015        PMID: 25789224      PMCID: PMC4352228          DOI: 10.5681/apb.2015.012

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  46 in total

1.  Involvement of K(ATP) channels in diethylstilbestrol-induced relaxation in rat aorta.

Authors:  C Martínez; M Sánchez; A Hidalgo; M J García de Boto
Journal:  Eur J Pharmacol       Date:  2001-02-09       Impact factor: 4.432

Review 2.  Effects of estrogen on the vascular system.

Authors:  R C Tostes; D Nigro; Z B Fortes; M H C Carvalho
Journal:  Braz J Med Biol Res       Date:  2003-08-19       Impact factor: 2.590

Review 3.  Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors:  D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

4.  Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, induces dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels.

Authors:  Tsuneaki Omae; Taiji Nagaoka; Ichiro Tanano; Akitoshi Yoshida
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-24       Impact factor: 4.799

5.  Vasorelaxant Effect of a Newly Synthesized Dihydropyridine Ethyl Ester (DHPEE) on Rat Thoracic Aorta: Dual Mechanism of Action.

Authors:  Hossein Babaei; Farzaneh Ebrahimi; Javid Shahbazi Mojarrad; Yadollah Azarmi; Afsaneh Gharehbagheri
Journal:  Adv Pharm Bull       Date:  2011-07-20

6.  Cooling and response to hydrogen peroxide in human saphenous vein: role of the endothelium.

Authors:  Ayşe Saide Sahin; Kismet Esra Atalik; Tahir Kemal Sahin; Necdet Doğan
Journal:  Fundam Clin Pharmacol       Date:  2005-06       Impact factor: 2.748

Review 7.  Androgens and cardiovascular disease.

Authors:  Peter Y Liu; Alison K Death; David J Handelsman
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

8.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

9.  Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin.

Authors:  C A Gruetter; D Y Gruetter; J E Lyon; P J Kadowitz; L J Ignarro
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

10.  Inhibition of nitric oxide synthesis by methylene blue.

Authors:  B Mayer; F Brunner; K Schmidt
Journal:  Biochem Pharmacol       Date:  1993-01-26       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.